Revolade receives positive opinion in Europe

revolade   Dan revolade

Revolade is the first approved therapy in the EU for patients with severe aplastic anemia who have not responded to other treatments

Revolade is a once-daily oral thrombopoietin receptor agonist that works by inducing stimulation and differentiation of megakaryocytes ( Revolade is the first approved therapy in the EU for patients with severe aplastic anemia who have not responded to other treatments

आज का इंडिया का मैच REVOLADE GLAXOSMITHKLINE Click on a Brand to view Alternate Brands of same Drug dosage Retail Rs REVOLADE, [ Revolade is a once-daily oral thrombopoietin receptor agonist that works by inducing stimulation and differentiation of megakaryocytes (